Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Johnson & Johnson | 33 | 1 | 3 | 0 | €138.50 | €195.83 | 41.396% |
| Incyte Corp. | 12 | 2 | 3 | 0 | €53.14 | €78.42 | 47.577% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 4 | 0 | €907.40 | €958.32 | 5.611% |
| Pfizer Inc. | 27 | 4 | 1 | 0 | €26.54 | €40.66 | 53.230% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €283.55 | €297.31 | 4.853% |
| Gilead Sciences Inc | 11 | 1 | 3 | 0 | €61.22 | €84.81 | 38.536% |
| AbbVie Inc. | 22 | 0 | 4 | 0 | €146.46 | €175.11 | 19.562% |
| Eli Lilly Corp. | 51 | 0 | 6 | 0 | €747.40 | €781.33 | 4.540% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €121.40 | €124.93 | 2.907% |
| Abbott Laboratories | 17 | 0 | 1 | 0 | €96.45 | €116.71 | 21.009% |
| Vertex Pharmaceuticals Inc. | 46 | 2 | 6 | 0 | €417.15 | €423.03 | 1.410% |
| Zoetis Inc. A | 23 | 1 | 3 | 0 | €158.12 | €200.06 | 26.523% |
| Biogen Inc. | 49 | 1 | 9 | 1 | €201.80 | €293.57 | 45.477% |